Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1370 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

CASE REPORT Table of Contents   
Year : 2019  |  Volume : 30  |  Issue : 1  |  Page : 235-238
IgM nephropathy – Successful treatment with rituximab

1 Hospitalist Department, OSF Saint Anthony Medical Centre, Rockford, Illinois, USA
2 Division of Nephrology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Correspondence Address:
Faheemuddin Azher Ahmed
Hospitalist Department, OSF Saint Anthony Medical Center, Rockford, Illinois
Login to access the Email id

DOI: 10.4103/1319-2442.252917

PMID: 30804288

Rights and Permissions

Immunoglobulin M nephropathy (IgMN) is a primary glomerulonephritis which is characterized by variable degrees of morphological features ranging from minimal glomerular involvement to segmental or global sclerosis. No specific treatment is known to date for this disease because of uncertainties in etiopathogenesis. The mainstay treatment for this disease has been corticosteroids, which has varying degrees of resistance ranging from 0% to 50%. We present the case of a 59-year-old Caucasian male who was referred to the outpatient nephrology clinic for the evaluation of proteinuria and was diagnosed with IgMN. We successfully treated the patient with rituximab with resolution of his proteinuria.

Print this article  Email this article

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded343    
    Comments [Add]    

Recommend this journal